Unusual Options Activity: TJX Companies (TJX)
Retail chain TJX Companies (TJX) is up nearly 50 percent over the past year, although the stock has come down in the past few weeks. One trader sees a strong rebound in the coming weeks. That’s based on the October $96 calls. With 24 days left until expiration, 20,393 contracts traded compared to a prior open interest of 235, for an 87-fold rise in volume on the trade. The buyer of the calls paid $0.12 to make the bullish bet. Shares recently ...
Read More About This
Read More About This
Higher Fees Mean Higher Profits for the Right Companies
No matter how you slice it, companies need to make a profit. That means they need to make money even after all the costs of business. So when those costs rise, so do the prices consumers pay. It can also mean changing returns for investors. For instance, investors in a franchise need to have deep pockets to invest. Most franchise companies require an up-front financial commitment. Increasing those fees is a sign of higher profitability for the management company. After 30 years ...
Read More About This
Read More About This
Insider Activity Report: Asana (ASAN)
Dustin Moskovits, President and CEO at Asana (ASAN), recently bought 1,015,000 shares. The buy increased his stake by 2 percent, and came to a total cost of $18,310,600. This is his second buy of the month, following a 554,847 share pickup on September 8. And this is his 19th buy so far this year. A few company insiders have been sellers of shares this year, with some of those sales coming from the exercise of stock options. Overall, Asana insiders own Read More About This
Unusual Options Activity: Palantir Technologies (PLTR)
Big data firm Palantir Technologies (PLTR) has doubled over the past year, but shares are well off their highs and have slid in recent weeks. One trader sees further weakness ahead. That’s based on the October $12.50 puts. With 25 days until expiration, 9,233 contracts traded compared to a prior open interest of 148, for a 62-fold rise in volume on the trade. The buyer of the puts paid $0.29 to make the bearish bet. Shares recently traded for about $14.00. So ...
Read More About This
Read More About This
Buy Income-Producing Defensive Stocks on Sale
When it comes to shopping at a store, consumers love a deal. Yet when those same consumers are shown a declining stock price, their first instinct is to avoid or sell, not buy. Investors who can look past that trend and look to buy when a stock is on sale can get a good deal. And a sale typically won’t last long on a great, industry-leading company. Taking advantage of those deals can lead to great investment returns over time. One deal ...
Read More About This
Read More About This
Insider Activity Report: Broadcom (AVGO)
Harry You, a director at Broadcom (AVGO), recently added 1,000 shares. The buy increased his stake by 40 percent, and came to a total cost just under $859,000. The buy comes a week after another director, Check Low, bought 11,000 shares, increasing his stake by 22 percent, and paying just under $9.6 million. These mark the first two insider buys since March 2022, otherwise, company insiders, mostly directors, have been sellers of shares. Overall, Broadcom insiders own 2.3 percent of shares. The ...
Read More About This
Read More About This
Unusual Options Activity: Edwards Lifesciences (EW)
Medical device manufacturer Edwards Lifesciences (EW) is down 14 percent over the past year, with shares taking a beating in recent sessions. One trader sees a potential rebound ahead in the coming weeks. That’s based on the October $82.50 calls. With 28 days until expiration, 5,738 contracts traded compared to a prior open interest of 209, for a 27-fold rise in volume on the trade. The buyer of the calls paid $0.55 to make the bullish bet. Edwards shares recently traded ...
Read More About This
Read More About This
Bad News Can Prove Good News for Patient Investors
Markets tend to react quickly to news. However, markets don’t just react. They tend to overreact. When there’s good news, the price of a company can get pushed far higher than it should. And when bad news hits, shares tend to sell off more than they should. Patient investors can use this to their advantage. They can buy when there’s bad news surrounding a company. And then take some profits when good news sends shares higher than they would otherwise go. Right ...
Read More About This
Read More About This